(Q58476517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

1 November 2019

main subject

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

B C P Polak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Crijns

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A F Casparie

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

89-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

Photocoagulation for Diabetic Macular Edema

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Relation of glycemic control to diabetic microvascular complications in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Quality of outpatient care provided to diabetic patients. A health maintenance organization experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The evolving care of diabetes. Models, managed care, and public health

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Cost effectiveness of current approaches to the control of retinopathy in type I diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Cost-effectiveness of detecting and treating diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Model of complications of NIDDM. I. Model construction and assumptions.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Visual impairment in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Association of Differing Dietary, Metabolic, and Clinical Risk Factors with Macrovascular Complications of Diabetes: A Prevalence Study of 503 Mexican Type II Diabetic Subjects. I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

The Natural History of Retinopathy in Insulin-Dependent Juvenile-Onset Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Impact of Late Complications in Type 2 Diabetes in a Dutch Population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Relation of ocular and systemic factors to survival in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2802%2900143-4

7 January 2021

10.1016/S0168-8510(02)00143-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12644331%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference